These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 21668522

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
    Pappas PG, Rotstein CM, Betts RF, Nucci M, Talwar D, De Waele JJ, Vazquez JA, Dupont BF, Horn DL, Ostrosky-Zeichner L, Reboli AC, Suh B, Digumarti R, Wu C, Kovanda LL, Arnold LJ, Buell DN.
    Clin Infect Dis; 2007 Oct 01; 45(7):883-93. PubMed ID: 17806055
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Economic analysis of micafungin versus liposomal amphotericin B for treatment of candidaemia and invasive candidiasis in Germany.
    Cornely OA, Sidhu M, Odeyemi I, van Engen AK, van der Waal JM, Schoeman O.
    Curr Med Res Opin; 2008 Jun 01; 24(6):1743-53. PubMed ID: 18477422
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.
    Maertens JA, Madero L, Reilly AF, Lehrnbecher T, Groll AH, Jafri HS, Green M, Nania JJ, Bourque MR, Wise BA, Strohmaier KM, Taylor AF, Kartsonis NA, Chow JW, Arndt CA, DePauw BE, Walsh TJ, Caspofungin Pediatric Study Group.
    Pediatr Infect Dis J; 2010 May 01; 29(5):415-20. PubMed ID: 20431381
    [Abstract] [Full Text] [Related]

  • 8. Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei.
    Shorr AF, Wu C, Kothari S.
    J Antimicrob Chemother; 2011 Feb 01; 66(2):375-80. PubMed ID: 21147825
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Safety of micafungin in pediatric clinical trials.
    Arrieta AC, Maddison P, Groll AH.
    Pediatr Infect Dis J; 2011 Jun 01; 30(6):e97-e102. PubMed ID: 21378595
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of micafungin for invasive candida infections: a meta-analysis of randomized controlled trials.
    Chen Q, Lin MH, Chen ML, Liu ZY, Chai D, Wang R.
    Chin Med J (Engl); 2012 Jan 01; 125(2):345-51. PubMed ID: 22340571
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and Safety of Echinocandins for the Treatment of Invasive Candidiasis in Children: A Meta-analysis.
    Tsekoura M, Ioannidou M, Pana ZD, Haidich AB, Antachopoulos C, Iosifidis E, Kolios G, Roilides E.
    Pediatr Infect Dis J; 2019 Jan 01; 38(1):42-49. PubMed ID: 29596219
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Micafungin in invasive candidiasis among oncohematological patients].
    Jarque I, Angel Sanz M.
    Rev Iberoam Micol; 2009 Mar 31; 26(1):75-7. PubMed ID: 19463282
    [Abstract] [Full Text] [Related]

  • 18. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.
    Cross SA, Scott LJ.
    Drugs; 2008 Mar 31; 68(15):2225-55. PubMed ID: 18840009
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.